Description
BLOOD AND BLOOD PRODUCTS FOR PATIENTS.
First action · last action
2025-10-01 · 2025-10-01
Transactions
1
First transaction's obligation
$594,875
Base + all options value (sum of deltas)
$594,875
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C24926A0003
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-10-01+$594,875= $594,875
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-10-01 | +$594,875 | $594,875 | BLOOD AND BLOOD PRODUCTS FOR PATIENTS. |
Related awards · 9
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Z9HUQ54LMDR4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926A0003 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24925P0025 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $399,994 | FY2025 |
| 36C24924P0025 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $377,262 | FY2024 |
| 36C24923P0025 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $439,409 | FY2023 |
| 36C24922P0013 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,219 | FY2022 |
| 36C24921P0033 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $404,782 | FY2021 |
Other recipients under 6506 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926N0133 | LIFESHARE BLOOD CENTER | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $390,791 | FY2026 |
| 36C24925N0158 | LIFESHARE BLOOD CENTER | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $162,074 | FY2025 |
| 36C24924D0098 | LIFESHARE BLOOD CENTER | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $0 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24926N0200_3600_36C24926A0003_3600 · retrieved 2026-09-27.